Upon being FDA approved in December 2025, the Wegovy pill became the first version of oral semaglutide (as well as the first oral GLP-1) specifically approved for weight loss
Section 11: Conclusion Section 11: Conclusion The exploration of Semaglutide and Wellbutrin within this comprehensive review has illuminated the distinct and complementary roles these medications can play in managing complex health conditions such as type 2 diabetes, obesity, and depression
Some other GLP-1 injectable drugs include Mounjaro, Trulicity, and Saxenda, but if you cant tolerate any GLP-1 drugs, you may be able to take a medication like Rybelsus or Jardiance
What makes adding glucagon a game changer is that glucagon supports the breakdown of stored fat and could even increase energy expenditure
Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, et al
Current research on semaglutide extends well beyond its approved indications, with numerous ongoing trials investigating potential applications in various disease states